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The unique biology of RNA binding proteins is altering our view of the genesis of protein
misfolding diseases. These proteins use aggregation of low complexity domains (LCDs)
as a means to regulate the localization and utilization of RNA by forming RNA granules,
such as stress granules, transport granules and P-bodies. The reliance on reversible
aggregation as a mechanism for biological regulation renders this family of proteins
highly vulnerable to promoting diseases of protein misfolding. Mutations in RNA binding
proteins are associated with many neurodegenerative disorders, such as amyotrophic
lateral sclerosis (ALS) and frontotemporal lobar dementia (FTLD). The biology of RNA
binding proteins also extends to microtubule associated protein tau. Tau is normally an
axonal protein, but in stress it translocates to the somatodendritic arbor where it takes on
a new function promoting formation of stress granules. The interaction of tau with stress
granules also promotes tau aggregation, accelerating formation of the tau pathology that
we associate with diseases such as Alzheimer’s disease (AD).
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INTRODUCTION
Pathological protein aggregation is a hallmark of neurodegenerative disorders such as
Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Frontotemporal lobar dementia (FTLD), and
Amyotrophic Lateral Sclerosis (ALS). Classically, this aggregation has been viewed as the byproduct
of protein misfolding and/or impairment of protein catabolism. In this model, misfolded proteins
and protein oligomers accumulate because of increased production or reduced removal. The
amount of misfolded protein and oligomer is thought to depend primarily on the initial amount of
starting protein and its natural propensity to aggregate. The accumulating misfolded proteins and
oligomers lead to the uncoordinated assembly of higher order oligomers, amyloids and eventually
large fibrils, which harm the cell and precipitate neurodegeneration.
Over the past decade an increasing body of work investigating the unusual biology of RNA
binding proteins (RBPs) has shed new insight into mechanisms of protein aggregation in disease
(Li et al., 2013). RBPs represent a class of over 800 proteins responsible for the regulation of mRNA
maturation in the nucleus as well as mRNA translation in the cytoplasm. The domain structure of
these proteins typically includes RNA recognition motifs, aggregation promoting low complexity
domains (LCDs), and nuclear import and export sequences (Lunde et al., 2007; King et al., 2012;
Espinosa Angarica et al., 2014). Importantly, RBPs form a variety of RNA-protein (RNP) granules
that are critical for RNA metabolism; these granules include processing-bodies (P-bodies), stress
granules (SGs), nuclear granules, and/or transport granules (Kedersha et al., 1999). P-bodies are
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responsible for mRNA silencing and degradation, while SGs
function to suppress the translation of non-essential proteins in
favor of protective stress-response proteins. SGs are nucleated by
a core set of RBPs (see below) with their associated transcripts,
and maturation of the SG incorporates secondary RBPs,
additional transcripts, and proteins that enable interactions
with other organelles, such as microtubules, actin filaments,
autophagosomes and mitochondria (Buchan and Parker, 2009;
Vanderweyde et al., 2016).
RBPs share important genetic and pathological links with
neurological diseases (Table 1). Tar DNA binding protein (gene,
TARDBP; protein, TDP-43) is the primary component of
pathological aggregates in most cases of ALS as well as the 40% of
cases of FTLD associated with progranulin haplo-insufficiency;
in addition, mutations in TDP-43 proteins cause familial ALS.
As described in Table 1, mutations in FUS, hnRNPA1/B2
and other RBPs are associated with familial forms of motor
neuron disorders, while mutations in proteins associated with
formation or removal of RNA granules cause ALS, FTLD, other
motor neuron diseases as well as myopathies. Recent studies
from our laboratory also implicate RBPs such as TIA1 in the
pathophysiology of AD and other tauopathies (Vanderweyde
et al., 2012, 2016). Histopathological studies also implicate RBPs
in Huntington’s Disease (HD), and Creutzfeldt-Jakob Disease
(CJD). These discoveries have propelled extensive efforts to
understand how dysregulation of RBP aggregation leads to
neurodegenerative conditions.
RNP GRANULES AND THEIR RELEVANCE
TO NEURODEGENERATIVE DISORDERS
Stress Granules and P-Bodies
SGs and P-bodies are key RNP granules that transiently
consolidate cytoplasmic mRNAs. SGs form rapidly with cellular
stress; stress kinases phosphorylate translation initiation factor
eIF2α, which promotes polysome disassembly and SG formation
(Kedersha et al., 1999). Some of the core SG nucleating
RBPs include TIA1 (T-cell intracellular antigen 1), nucleolysin
(TIAR), tristetraprolin (TTP), fragile X mental retardation
protein (FMRP) and Ras-GAP SH3 Binding Protein 1 (G3BP1).
Aggregation of these core nucleating proteins to form SGs
initiates a process in which mRNAs stalled in translation are
sequestered, allowing RNA translation to shift toward synthesis
of cytoprotective proteins (Kedersha and Anderson, 2007). P-
bodies associate with SGs and exchange transcripts which are
subject to decapping and degradation (for detailed review on
RNP granule components and dynamics, see Protter and Parker,
2016).
RNP granules are dynamic, diverse structures, containing a
variety of RBPs, enzymes, remodeling proteins, and transcripts
(Protter and Parker, 2016). The nucleating components of RNP
granules can differ based on environmental conditions, the
mechanisms controlling granule formation, and cell type. SGs
also evolve with time, moving from small primary stress granules
to larger secondary stress granules (McDonald et al., 2011);
further evolution might occur as mature stress granules become
TABLE 1 | RNA binding proteins implicated in neurodegenerative
disorders.
RNA binding protein Abbreviation Associated diseases
TAR DNA-binding protein 43 TDP43 ALS*∧, FTLD*∧, AD∧, HD∧
T-cell intracellular antigen 1 TIA1 ALS∧, FTLD∧, AD∧
Ras GTPase-activating
protein-binding protein 1
G3BP1 ALS∧, FTLD∧, AD∧
Tristetraprolin TTP ALS∧, FTLD∧, AD∧
Fused in Sarcoma FUS ALS*∧, FTLD*∧
Ewing Sarcoma Protein EWS ALS*∧, FTLD*∧
TATA-Box Binding Protein
Associated Factor 15
TAF15 ALS*∧, FTLD*∧
Heterogeneous
Ribonucleoprotein Particle A1/A2
hnRNPA1/A2 ALS*, FTLD*
Angiogenin ANG ALS, PD*
Survival of motor neuron SMN1 ALS*, SMA*
Matrin-3 MATR3 ALS∧
Ataxin-2 ATXN2 ALS∧
Optineurin OPTN ALS*∧
Fragile X mental retardation
protein
FMRP FXS*
*Mutations linked to disease.
∧ Inclusions linked to disease.
ALS, Amyotrophic Lateral Sclerosis; FTLD, Frontotemporal Lobar Dementia; AD,
Alzheimer’s Disease; HD, Huntington’s Disease; PD, Parkinson’s Disease; FSX, Fragile
X Syndrome; SMA, Spinal Muscular Atrophy.
persistent pathological stress granules over the months to years
associated with human disease.
Initial evidence implicating stress granules in
neurodegenerative diseases arose from the seminal discovery that
TDP-43 is the primary pathological protein that accumulates
in sporadic ALS and many cases of FTD (Neumann et al.,
2006). Following this discovery, ALS-linked mutations were
identified in multiple RBPs, including TDP-43, FUS, ATXN2,
hnRNPA1, EWSR1, and TAF15 (Table 1). The disease-linked
mutations generally occur in the low complexity (LC) domains
of these proteins and increase the tendency of the proteins to
aggregate, which will be discussed in a later section (Johnson
et al., 2009; Liu-Yesucevitz et al., 2010; Kim et al., 2013);
mutations in other ALS-linked genes also stabilize stress granule
dynamics, including mutations in C9orf72, Valosin containing
protein (VCP) and Cu/Zn Superoxide Dismutase (SOD1)
(Buchan et al., 2013; Gal et al., 2016; Lee et al., 2016; Lin et al.,
2016).
Neuronal Transport RNP Granules
Neurons have a unique need for controlled transport of mRNAs
because of their lengthy processes and their need for activity
dependent translation at the synapse. These needs demand high
expression of RNP transport granules in the somatodendritic
arbor. Transport granules contain RBPs such as staufen, pamillo
and FMRP; these granules play important roles in mRNA
localization and activity-dependent translational control at the
synapse (Protter and Parker, 2016). Transport granules might
represent the sites where RBP dysfunction in disease is first
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evident. Studies of granule trafficking in living neurons show
that disease-linked mutations in RBPs, such as TDP-43, produce
granules that are innately larger and travel slower (Liu-Yesucevitz
et al., 2014). These larger, slower moving granules might be a
nidus for disease pathology, which could provide one mechanism
through which RBPs primarily might cause neuronal disease.
Nuclear RNP Granules
The nucleus is highly enriched for many RBPs responsible
for transcription and early RNA maturation events such as
splicing, capping, or nuclear export. A variety of RNP granules
organize these many critical functions, including coiled bodies,
PML bodies, Cajal bodies, nucleoli, speckles, gems, and histone
locus bodies (HLBs), but how nuclear RNP granule deficiency
contributes to neurodegenerative disorders is poorly understood.
Disease linked RBPs including FUS, EWS and TAF15 mediate
a DNA damage response through the formation of an RNP
granule around DNA breaks (Wang et al., 2013; Deng et al.,
2014). Dipeptide repeats produced by mutations in C9orf72
might also interfere with multiple nuclear functions (see below).
In addition, RBP45 is an RBP present in ALS, FTLD and AD
inclusions that is associated with nuclear splicing pathways (Li
et al., 2016), while transcriptomic studies from ALS patients
have revealed trends in RNA editing errors and disease related
differences in splicing alterations (Prudencio et al., 2015).
Crosslinked immunoprecipitation (iCLIP) studies of TDP-43 and
FUS indicate that TDP-43 exhibits a preference for binding
long transcripts of neuron enriched proteins, and FUS appears
to function as a marker for RNA polymerase elongation
(Polymenidou et al., 2011, 2012). These studies highlight a
potentially important role for nuclear RNA metabolism in ALS.
C9orf72 and RNA Foci in ALS
Hexanucleotide repeat expansions in a non-coding region of the
gene C9orf72 (C9) produce pleotropic pathology that are a major
cause of familial ALS, and also contribute to other neurological
diseases. This mutant expansion was initially identified and
found to induce the formation of RNA foci from the sense
strand of the C9 mRNA (DeJesus-Hernandez et al., 2011; Renton
et al., 2011). Mutant C9 also produces a non-canonical form
of translation generating 6 different dipeptide repeats (DPRs)
that accumulate as aggregates in diseased brains (Ash et al.,
2013; Mori et al., 2013a). C9 pathology also exhibits nuclear
to cytoplasmic translocation of TDP-43 and formation of TDP-
43 inclusions, pathologies which cause many problems (Lee
et al., 2012). RNA foci resulting from mutant C9 transcripts
recruit a large variety of RBPs (Mori et al., 2013b), and DPRs
appear to interfere withmultiple functions, including those of the
nucleolus, the nuclear pore and other RBPs (Kwon et al., 2014;
Jovicic et al., 2015; Lee et al., 2016; Lin et al., 2016). C9orf72
repeats have been shown to affect stress granule formation in cell
N2A cells and in cortical neurons using the response to protein
synthesis inhibitors as a marker of stress granule function. The
protein synthesis inhibitor puromycin allows the ribosome to
run-off the mRNA, causing the accumulation of naked mRNA,
which promotes stress granule formation; the protein synthesis
inhibitor cycloheximide stalls ribosomes on mRNA, which hides
the mRNA and inhibits stress granule formation. C9orf72 repeat
foci co-localize with TIA1 puncta in the cytoplasm in response
to puromycin, but not in response to cycloheximide (Maharjan
et al., 2016). Conversely, CRISPR mediated deletion of C9
inhibits stress granule formation (Maharjan et al., 2016), while
overexpressing C9 leads to stress granule formation in the
absence of stressors. For a detailed review of the evolving research
into the pathophysiology of C9 disease see the review by Todd
and Petrucelli.
HOW DO RNP GRANULES TRANSITION
FROM A HEALTHY TO PATHOLOGICAL
STATE?
Phase Separation as the First Step to
Fibrillization
A key feature of many RBP sequences is the presence of a “prion-
like” LCD enriched in uncharged polar amino acids (King et al.,
2012). Typically, these sequences are at least 60 amino acids
longs, are predicted to be intrinsically unfolded, and enable the
replication of a particular protein conformation from one copy to
another (Couthouis et al., 2011). The LCDss are also conducive
to mathematical modeling based on glutamine and asparagine
enrichment, and such modeling has shown that many of the
disease-linked RBPs are those which have the greatest tendency to
aggregate (Michelitsch and Weissman, 2000; Alberti et al., 2009;
Zambrano et al., 2015).
RBPs appear to form RNP granules through a process of
liquid-liquid phase separation (LLPS) mediated by their LCDss
(Lin et al., 2015). LLPS refers to a biochemical process which
forms distinct, non-membrane bound complexes within the
cytoplasm that behave in a manner analogous to oil droplets
in an aqueous solution. LLPS is hypothesized to allow RNA
granules to be particularly dynamic, being sufficiently stable to
facilitate processes such as RNA transport but also sufficiently
dynamic to interact with the surrounding cytosol and readily
disperse when acted on by cellular disaggregases (e.g., VCP,
Hsp110 or DNAJB1), chaperones (e.g., FKBPs) or signaling
mechanisms. Studies using recombinant proteins or cell lines
indicate that the RBPs hnRNPA1 and FUS cycle through LLPS
in a process that is dependent on the C-terminal LCDss
(Figure 1; Molliex et al., 2015). Upon repetitive cycling, a small
fraction of the protein misfolds to form highly stable amyloids;
disease-linked mutations in these proteins strongly increase the
likelihood to form such amyloids, perhaps providing the basis
for the persistent pathological inclusions that accumulate in
ALS (Figure 1; Murakami et al., 2015; Patel et al., 2015). The
biophysical mechanisms leading to TDP-43 pathology, though,
are less clear (Johnson et al., 2009; Liu-Yesucevitz et al., 2010;
Conicella et al., 2016). While TDP-43 readily forms stable
aggregates and stable stress granules in vitro and in cultured
neurons, recombinant forms of TDP-43 do not readily form
hydrogels or undergo LLPS, and ALS-associated mutations in
TDP-43might even disrupt phase separation and self-interaction.
LLPS provides a compelling mechanistic link between
the low complexity prion domains in disease related RBPs
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FIGURE 1 | Liquid-liquid phase separation contributes to RNP granule dynamics and eventual fibrillization. Within the cytosol, RNA binding proteins
(RBPs) containing low complexity prion-like domains (LCDs) exist in an unaggregated state. Upon activating signaling cascades, the LCDs mediate weak aggregation
through liquid-liquid phase separation, creating a distinct compartment enriched in RBPs, RNA and other associated proteins. Importantly, these ribonucleoprotein
granules maintain the ability to exchange material with the cytosol while in this state, which allows them to carry out key mRNA regulating events. However, persistent
aggregation over time or other pathological insults can drive these RBPs to further aggregate into compact, stable fibrils. In this model, the fibrillar forms of these
granules can no longer exchange material with the surrounding cytosol and effectively trap their components in the granule.
and the pathological aggregation of RBP nucleated granules.
The simplicity of the experimental systems used for the
studies described above provides powerful strengths as well as
weaknesses. Use of purified recombinant proteins in in vitro
studies allows rigorous analysis of the biophysical properties of
the RBPs. Such studies might ultimately provide valuable insights
into the mechanisms through which differing mutations can
produce distinct disorders, such as is observed for the continuum
of disease between ALS and FTD. However, these studies do not
address two important issues. The first issue is the biological
complexity of neurons, which have multiple levels of regulation
provided by chaperones, post-translational modifications, RNA,
disaggregates, the autolysosomal system, as well as the deleterious
effects of aging. The second issue is the question of whether more
aggregation is good or bad. Multiple different studies suggest
that oligomers are more toxic to neurons than large inclusions,
such as PrP, polyQ aggregates, Aβ plaques or neurofibrillary
tangles (Arrasate et al., 2004; Santacruz et al., 2005; Silveira et al.,
2005). For mechanisms of toxicity that are caused directly by
aggregates, the accumulation of small oligomers might be more
toxic than the accumulation of large inclusions. Conversely, large
inclusions could be important for mechanisms of toxicity that
arise loss of function due to sequestration of proteins, such as
RBPs, in insoluble aggregates similar to stress granules or large
nuclear inclusions. Thus, although LLPS provides an appealing
mechanism to explain how aggregation might be initiated, care
must be taken when considering how this paradigm might
translate to the brain.
Tau Pathology Promotes the Formation of
Insoluble RBP Aggregates
The microtubule associated protein tau is a multi-functional
protein that is natively disordered, aggregation prone, and can
disrupt protein homeostasis through several knownmechanisms.
Notably, it has been shown that increased levels of pathological
tau lowers protein synthesis in vitro and in vivo (Meier
et al., 2016). Over-expression of P301L mutant tau in rTg4510
mice upregulates the stress kinase PERK, leading to eIF2α
phosphorylation, translation inhibition, and synapse loss (Meier
et al., 2015; Vanderweyde et al., 2016). Inhibition of PERK
ameliorates these deficits (Vanderweyde et al., 2016). Tau also
affects protein translation through direct interaction with the
ribosomes and RBPs. These interactions are both altered in AD,
where association with RBPs is increased (Meier et al., 2016).
Tau also modulates trafficking of RNA granules, with retrograde
trafficking affected more than anterograde motion (Vanderweyde
et al., 2016).
New evidence identifying a novel mechanism through which
tau alters protein homeostasis indicates that tau interacts
with TIA1, a core SG nucleating protein, and other RBPs
(Figure 2). Tau pathology increases somatodendritic localization
of TIA1, which is predominantly nuclear in healthy or unstressed
cells (Vanderweyde et al., 2016). Tau/TIA1 complex formation
accelerates the dynamics of SG formation, increases SG size,
and concomitantly escalates tau aggregation. Disease-linked
mutations enhance the effects of tau on SGs, with P301L tau
generating TIA1 SGs that are larger but fewer in number than
those formed in cells expressing WT tau (Vanderweyde et al.,
2016). Extracellular tau aggregates also increase SG formation
raising the possibility that tau propagation also contributes to
formation of pathological SGs (Brunello et al., 2016). Tau also
modifies the TIA1 interactome, where multiple RBPs including
SNRNP70, EWSR1, TAF15, and several ribosomal proteins form
complexes with TIA1 in a tau dependent manner (Vanderweyde
et al., 2016). It is important to note that the effects of tau on SG
dynamics are TIA1 specific; TDP-43 and FUS do not co-localize
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FIGURE 2 | Interaction of Tau and RBP pathologies: (1) RBPs such as TIA1 splice RNA in the nucleus, and shuttle in and out of the nucleus. Although TIA1 is
normally predominantly nuclear, Tau slows nuclear/cytoplasmic transport, decreasing anterograde transport less than retrograde transport, overall favoring a
cytoplasmic localization of TIA1. (2) Tau binds to the small subunit of ribosomes, and this interaction changes in taupathies such as AD, resulting in stalled translation.
Stalled translation initiation complexes containing mRNA and the small ribosomal subunit forms complexes with ribosomal proteins, mRNA, and core SG nucleating
RBPs. (3) Small core stress granules forms complexes with additional RBPs including DDX helicases. (4) Tau increases the size of stress granules, and influences the
specificity of RBPs included in stress granules. RBPs in complex with Tau and TIA1 include TAF15 and EWSR1. (5) TIA1 mediates interaction of stress granules with
insoluble tau aggregates internalized from the cytoplasm (Meier et al., 2015; Brunello et al., 2016; Vanderweyde et al., 2016).
with tau, nor do the RBPs G3BP and TTP despite being core
nucleating SG proteins (Vanderweyde et al., 2012). Thus, tau
appears to selectively regulate SGs containing TIA1 as a core
component (Figure 2).
The interaction of tau with SGs is a two way street
that has important implications for disease mechanisms,
and possibly for disease therapy. The interaction of TIA1
with tau increases the tendency of tau to form sarkosyl
insoluble aggregates, and stabilizes tau dynamics (Vanderweyde
et al., 2016). This means that the interaction of tau with
SGs and perhaps other RNA granules might be previously
undiscovered mechanism propelling tau aggregation and tau-
mediated neurodegeneration (Figure 2). Conversely, knock
down of TIA1 in primary hippocampal neurons reduces levels of
misfolded tau, prevents acute toxicity associated with expressing
P301L tau (Vanderweyde et al., 2016). The latter observation
raises the possibility that reducing TIA1 might delay disease
progression in tauopathies.
DEREGULATION OF STRESS GRANULE
REMOVAL CONTRIBUTES TO DISEASE
The dynamic nature of RBP aggregation to form SGs and other
RNA granules provides a sharp contrast with the classic view
of aggregation processes in neurodegeneration. RBP aggregation
is readily reversible, and SGs formed by an acute stress also
disperse just as rapidly following removal of stress (Protter and
Parker, 2016). SG dispersal uses some of the same pathways
responsible for clearing aggregated proteins, including heat
shock protein chaperones, ubiquitin, p62/SQUSTM, proteasomal
degradation and autophagy. Timely clearance of stress granules
and interacting aggregating proteins such as tau and C9ORF72
are crucial for re-initiation of mRNA translation, as well as
prevention of buildup of intrinsically disordered proteins that
are prone to aggregation. Failure to clear stress granules,
prion domain containing RBPs, and stress granule associated
disordered proteins such as tau may lead to pathological protein
aggregates (Wolozin, 2012; Protter and Parker, 2016).
Heat Shock Proteins
Heat shock chaperones (HSPs) play a key role in responding
to many of the same cell stressors that induce stress granules.
While stress granules sequester non-essential mRNAs in the
cytoplasm, heat shock transcripts are still translated. HSPs reduce
protein misfolding and target existing misfolded/aggregated
proteins for degradation, protecting neurons from injury caused
by the accumulation of misfolded/aggregated proteins. Binding
of HSPs to the LCDs of RBPs reduces their aggregation
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propensity; binding to the disordered domains of proteins
such as tau or α-synuclein reduces the assembly of these
aggregation prone regions as well. Hsp27 interacts directly with
tau, specifically hyper-phosphorylated tau and PHFs (Abisambra
et al., 2010). Studies with recombinant proteins and in vivo
indicate that Hsp27, along with Hsp90 and other chaperones,
promote maintenance of soluble tau, and reduction of tau fibrils
(Abisambra et al., 2010). Hsp70 also enables tau solubility and tau
interaction with microtubules (Abisambra et al., 2010). Whether
tau association with stress granules and RBPs affects interaction
with HSPs is unknown, but is an important outstanding question.
HSPs survey the proteome, and target misfolded proteins
that must be degraded for ubiquitination. This process is crucial
for clearance of misfolded tau, as aggregates containing both
ubiquitin and tau occur in AD and FTLD-U. This surveillance
function is mediated by the interaction of Hsp70 with CHIP, a
E3 ubiquitin ligase; CHIP knockout mice exhibit increased tau
pathology, while overexpression of CHIP has the opposite effect
(Dickey et al., 2006). Ubiquitination becomes important in the
SG cascade because it provides a major mechanisms through
which persistent SGs can be targeted for clearance through
autophagy and the UPS.
Ubiquitin, Autophagy, and Stress Granules
The importance of clearing protein aggregates to
neurodegenerative diseases is apparent in protein catabolism
genes linked to FTD, ALS, or myopathies, and stress granules
are also disassembled by components of the proteasome and
autophagy/lysosmal degradation pathways (Buchan et al.,
2013). Mutations in SQSTM1/p62, ubiquilin-2 and VCP are
all associated with familial forms of ALS, FTD or myopathy
(Deng et al., 2011; Rubino et al., 2012). VCP is a disaggregase
that functions in SG clearance, although it is a complicated
molecule with many different activities (Buchan et al., 2013).
P62/SQSTM1 and ubiquilin-2 both function in identifying
pathological aggregates, such as persistent pathological SGs,
and targeting them for removal. Mutations in SQSTM1 likely
interfere with its function in targeting ubiquitinated proteins,
including tau, for proteasomal degradation. Other genes linked
to ALS and FTD, such as Tmem106b, Chmp2b, Tbk1, and
Optineurin, have functions as adapter proteins that recognize
ubiquitin tagged proteins. GRN, Tmem106B, and Chmp2b are
also necessary for lysosmal function in autophagy.
TARGETING STRESS GRANULE
FORMATION IN NEURODEGENERATIVE
DISEASES
Stress Kinase Activation of eIF2α
SG formation can be triggered by a variety of cellular
stressors including heat or cold shock, osmotic shock, nutrient
deprivation, ROS, or the unfolded protein responses (UPR)
(Radford et al., 2015). These stresses activate stress kinases, which
phosphorylate 40S-eukaryotic initiation factor 2 (eIF2α) and
prevent further translation initiation. Non-phosphorylated eIF2α
normally forms complexes with methionine tRNA and GTP as
part of the RNA translation initiation complex (Kedersha et al.,
1999). However, phosphorylation of eIF2α increases binding
of eIF2α to eIF2B, which prevents the exchange of GDP for
GTP and inhibits translation initiation (Kedersha et al., 1999).
Phosphorylation of eIF2α is reversible through Growth Arrest
and DNA Damage-inducible Protein 34 (GADD34), which is an
adapter protein that recruits phosphatase Protein Phosphatase 1
(PP1). Dephosphorylation of eIF2α stimulates SG disassembly,
which allows re-initiation of normal translation (Kedersha et al.,
1999).
There are four core stress activated kinases that phosphorylate
eIF2α: Protein Kinase R (PKR), PKR-like/Pancreatic
Endoplasmic Reticulum kinase (PERK), Heme-Regulated
Inhibitor (HRI), or General Control Non-derepressible 2 (GCN)
(Taniuchi et al., 2016). PKR is activated by double stranded
RNA, enabling it to respond to viral infection (Taniuchi et al.,
2016). PKR appears to respond to viral activation of the unfolded
protein response (UPR), and perhaps because of this, PKR also
responds to the presence of aggregated Aβ and PRNP (Chang
et al., 2002; Goggin et al., 2008). PERK also responds to the
accumulation of misfolded or aggregated proteins as part of
the UPR. PERK is activated in multiple different models of
neurodegeneration, including those caused by overexpressing
PrP, TDP-43, and tau (Moreno et al., 2013; Kim et al., 2014;
Radford et al., 2015). PERK inhibition by inhibitors such
as GSK20606414 restores translation and protects against
degeneration in these models (Kim et al., 2014; Radford et al.,
2015). Unfortunately, the clinical utility of PKR inhibitors might
be limited by the risk that they will allow activation of latent
viruses in elderly patients, while PERK inhibitors cause severe
pancreatic toxicity (Yu et al., 2015). GCN2 is activated by nutrient
deprivation, specifically the absence of essential amino acids,
and by activation of the ubiquitin-proteasome system (UPS).
GCN2 deletion protects against memory loss in a APP/PS1
mouse model, but not in a 5xFAD APP mouse model (Devi and
Ohno, 2013; Ma et al., 2013). HRI is activated by oxidative stress
induced by osmotic, heat shock, or arsenite, but has yet to be
studied directly in neurodegeneration (Lu et al., 2001).
eIF2α-Independent Inhibition of Translation
Initiation
Translation can also be stalled through eIF2α independent
mechanisms acting directly on components of the ribosome,
particularly the small subunit involved in preinitation complexes
(Kedersha and Anderson, 2007). Activated eIF2α binds to
mRNA, but needs to interact with the eIF4F complex for
initiation of translation. The eIF4F complex consists of eIF4A,
B, E and G, which bind mRNA through the RBP poly-A
binding protein (PABP). The role of the eIF4F complex in
neurodegeneration has yet to be studied in detail, but its potential
importance is evident when considering angiogenin, a protein
with mutations associated with ALS and PD (van Es et al., 2011;
Pan et al., 2015). The ribonuclease angiogenin cleaves tRNAs,
to produce tiRNAs (tRNA-derived stress induced fragments).
The 5’ ends of tiRNAs displace components of the pre-initiation
complex including eIF4G and eIF4A from mRNA, and displace
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eIF4F from the m7G mRNA cap (Ivanov et al., 2011). Mutations
in eIF4G1 are weakly associated with familial PD; in this case
the mechanism might lie in inappropriate aggregation with α-
synuclein, potentially leading to either a loss of eIF4F function
or a gain of α-synuclein aggregation (Siitonen et al., 2013;
Dhungel et al., 2015). These independent lines of genetic evidence
suggest a role for the eIF4F complex in the pathophysiology of
neurodegenerative disease.
Stalled Translation Initiation Complexes
Stalling of translation through eIF2α dependent or independent
pathways allows for disassembly of polyribosomes. The
determinant of SG formation lies in whether the ribosomes
remain associated with the transcripts. Stalling caused by
the protein synthesis inhibitor puromycin disassociates the
ribosome, producing naked transcript and initiating SG
assembly (Kedersha et al., 1999). In contrast, treatment with
the protein synthesis inhibitor cycloheximide leaves ribosomes
associated with transcripts and prevents SG formation (Kedersha
et al., 1999). Stalled translation initiation complexes contain
components of the 40S small ribosomal subunit, including eIF4E,
eIF4G, and eIF3, as well as PABP, a RBP that links eIF4 proteins
to the mRNA. SGs form when the stalled complex is bound by
core RBPs, such as TIA1, TIAR, TTP, or G3BP. The LC domains
of these proteins are necessary for SG formation, likely because
of the tendency of these LC domains to aggregate as described.
Mutant TIA1 lacking an RNA binding domain inhibits the
formation of stress granules, demonstrating the necessity of RNA
binding for the formation of stress granules (Kedersha et al.,
1999). As the SG matures, other RBPs are recruited, leading
to the growth of the SG and the binding of a wider array of
transcripts.
CONCLUSION
RNA binding proteins have a rich biology that integrates well
with our knowledge of the pathophysiology of neurodegenerative
diseases. The core biology derives from the presence of LC
domains that undergo LLPS, allowing for reversible aggregation
and sequestration of transcripts and other binding proteins.
This normally transient biological phenomenon appears to
become persistent and pathological in disease, resulting in
the interference the normal functions of RBPs and transcripts
through excessive segregation. Emerging evidence from several
laboratories demonstrate that tau protein contributes to SG
biology by promoting SG aggregation in a process that leads
to tau concomitant aggregation. In chronic disease, these
aggregated proteins become persistent and pathological, which
ultimately leads to the accumulation of aggregated protein,
disease pathology and neurodegeneration. Fortunately, SG
biology is regulated at multiple levels by a variety of pathways,
which provides entirely new targets of pharmacotherapy for
many neurodegenerative diseases, including ALS and AD.
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